IDEXX Laboratories, Inc. IDXX
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Ask Irving AI About IDXX
Get to know the stock you’re researching through a simple conversation. Ask Irving about its Weiss rating, financial health, dividends, and potential risks — right from the stock page.
Get answers about this stock. Instantly.
Ask about the company’s financial health and its Weiss Safety, Reward, and Risk Ratings, with answers grounded in Weiss Ratings data.
Understand the numbers behind the rating.
Explore profits, cash flow, valuation, and dividends. Ask follow-up questions without leaving the stock page.
Put the stock’s strengths and risks in context.
Look beyond a single number. Explore rating changes and company trends to better understand the stock’s outlook.
Company Overview
IDEXX Laboratories, Inc. is a U.S.-based diagnostics and software company focused primarily on veterinary healthcare, water testing, and livestock diagnostics. The company develops and markets diagnostic products, laboratory services, practice management software, and related technologies used by veterinarians, animal health professionals, and water testing laboratories. IDEXX operates primarily within the companion animal healthcare industry, where it is widely recognized for its integrated diagnostics ecosystem combining in-clinic instruments, reference laboratory services, consumables, and cloud-based software solutions.
The company’s principal revenue drivers include recurring sales of diagnostic consumables tied to its installed base of analyzers, veterinary reference laboratory testing services, and software subscriptions. IDEXX serves veterinary clinics, hospitals, corporate veterinary groups, and research institutions across global markets. A key strategic advantage is its large installed instrument base and integrated workflow platform, which creates recurring customer demand and high switching costs. Founded in 1983 in Maine, IDEXX evolved from a producer of diagnostic tests for livestock and water quality into a global companion animal diagnostics leader through product innovation, international expansion, and acquisitions in veterinary software and laboratory capabilities.
Business Operations
IDEXX organizes operations primarily through three business segments: Companion Animal Group (CAG), Water Quality Products, and Livestock, Poultry and Dairy (LPD). The Companion Animal Group represents the substantial majority of company revenue and includes in-clinic diagnostic instruments, consumables, rapid assay test kits, veterinary reference laboratory services, imaging systems, and veterinary software platforms. Recurring revenue is generated through consumable cartridge sales, laboratory testing volumes, software subscriptions, and service agreements linked to diagnostic instrument placements.
The company operates reference laboratories and commercial operations across North America, Europe, Asia-Pacific, and Latin America. IDEXX controls proprietary diagnostic technologies, data platforms, and veterinary workflow systems, including cloud-based practice management and diagnostic information services. Important subsidiaries and software assets include VetConnect PLUS, Neo, Cornerstone, and ezyVet. IDEXX has also established partnerships with veterinary corporate groups, distributors, and diagnostic service providers to expand adoption of its testing ecosystem and integrated clinical workflow solutions.
Strategic Position & Investments
IDEXX’s strategic direction centers on expanding companion animal healthcare diagnostics, increasing utilization of diagnostic testing in veterinary practices, and deepening customer integration through software and data connectivity. The company has consistently invested in menu expansion for diagnostic analyzers, artificial intelligence-enabled workflow tools, cloud software infrastructure, and global laboratory capacity. Management has emphasized recurring revenue growth through high-frequency consumable usage and software adoption tied to its installed instrument base.
Major acquisitions have strengthened IDEXX’s software and diagnostic portfolio, including the acquisitions of ezyVet, Animana, and Smart Flow to expand veterinary practice management and workflow capabilities. The company continues investing in telemedicine integration, diagnostic data analytics, and advanced testing technologies aimed at earlier disease detection in companion animals. IDEXX also maintains a significant presence in water microbiology testing through products used by municipalities and industrial laboratories for water safety compliance testing.
Geographic Footprint
IDEXX is headquartered in Westbrook, Maine, United States, and operates in more than 175 countries through direct operations, distributors, and laboratory networks. The company maintains significant commercial and laboratory operations across North America, Europe, Asia-Pacific, and Latin America, with international markets representing a substantial portion of total revenue. Major operational centers and laboratories are located in the United States, Canada, Germany, the United Kingdom, France, Australia, Japan, China, and other regional markets.
The company’s global footprint supports both direct veterinary clinic relationships and distributor-led market penetration strategies. IDEXX has expanded international investment in veterinary diagnostics infrastructure and software deployment to support rising companion animal healthcare spending globally. Its water testing products are also used internationally by government agencies, utilities, and industrial customers for regulatory compliance and public health monitoring.
Leadership & Governance
IDEXX operates under a leadership strategy focused on long-term innovation, recurring revenue expansion, customer integration, and disciplined capital allocation. The company’s governance structure emphasizes research and development investment, operational efficiency, and sustained growth in companion animal healthcare diagnostics. Founder David Evans Shaw played a central role in establishing the company’s diagnostics focus and early growth trajectory.
Key executives include:
- Jay Mazelsky – President and Chief Executive Officer
- Brian P. McKeon – Executive Vice President, Chief Financial Officer and Treasurer
- Jonathan W. Ayers – Executive Chair of the Board
- Jennifer K. Walters – Executive Vice President, Global Operations
- Sophie V. Vandebroek – Lead Independent Director
Information regarding leadership structure, operating segments, and financial reporting has been verified through publicly available disclosures including SEC filings, annual reports, investor presentations, and major financial reporting sources. Where operational details vary slightly across reporting periods due to segment reporting changes or executive transitions, information reflects the most consistently reported public data available.